Yarrow Bioscience, Inc. (YARW)

Yarrow Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Net Income	-283.98
Change in Accounts Payable	4.51
Change in Other Net Operating Assets	280.03
Operating Cash Flow	0.56
Operating Cash Flow Growth	-
Issuance of Common Stock	0.02
Other Financing Activities	-0.6
Financing Cash Flow	399.42
Net Cash Flow	399.98
Change in Working Capital	284.54

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error